BR9707922A - Cafeína e clemastina para tratamento de distúrbios respiratórios - Google Patents

Cafeína e clemastina para tratamento de distúrbios respiratórios

Info

Publication number
BR9707922A
BR9707922A BR9707922A BR9707922A BR9707922A BR 9707922 A BR9707922 A BR 9707922A BR 9707922 A BR9707922 A BR 9707922A BR 9707922 A BR9707922 A BR 9707922A BR 9707922 A BR9707922 A BR 9707922A
Authority
BR
Brazil
Prior art keywords
clemastine
caffeine
treatment
respiratory disorders
respiratory
Prior art date
Application number
BR9707922A
Other languages
English (en)
Inventor
Sekhar Mitra
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9707922A publication Critical patent/BR9707922A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9707922A 1996-03-05 1997-03-05 Cafeína e clemastina para tratamento de distúrbios respiratórios BR9707922A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/611,533 US5648358A (en) 1996-03-05 1996-03-05 Compositions and methods for treating respiratory disorders
PCT/US1997/003616 WO1997032586A1 (en) 1996-03-05 1997-03-05 Caffeine and clemastine for treating respiratory disorders

Publications (1)

Publication Number Publication Date
BR9707922A true BR9707922A (pt) 1999-07-27

Family

ID=24449410

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9707922A BR9707922A (pt) 1996-03-05 1997-03-05 Cafeína e clemastina para tratamento de distúrbios respiratórios

Country Status (9)

Country Link
US (1) US5648358A (pt)
EP (1) EP0886520A1 (pt)
JP (1) JP2000506167A (pt)
CN (1) CN1212625A (pt)
AU (1) AU1989697A (pt)
BR (1) BR9707922A (pt)
CA (1) CA2247500A1 (pt)
NZ (1) NZ331575A (pt)
WO (1) WO1997032586A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US5770618A (en) * 1996-11-13 1998-06-23 Nastech Pharmaceutical Company, Inc. Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
HUP0004813A2 (hu) * 1997-09-19 2001-08-28 The Procter & Gamble Co. Készítmények és eljárások légzési rendellenességek kezelésére
US5948414A (en) * 1998-03-24 1999-09-07 Nouveau Technologies, Inc. Herbal based nasal spray
US20030119915A1 (en) * 2001-04-16 2003-06-26 Anthony Booth (-)-Pseudoephedrine as a sympathomimetic drug
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
MXPA04002066A (es) * 2001-09-04 2005-02-17 Techno Network Shinoku Co Ltd Farmacos contra influenza.
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
US20040259809A1 (en) * 2003-06-17 2004-12-23 Pediamed Pharmaceuticals, Inc. Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof
US7522955B2 (en) * 2003-10-03 2009-04-21 Michael Rontal Method and apparatus for the ultrasonic cleaning of biofilm coated surfaces
US20060029664A1 (en) * 2004-08-04 2006-02-09 Sovereign Pharmaceuticals, Ltd. Dosage form containing carbetapentane and another drug
US20070053868A1 (en) 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
US7529255B2 (en) * 2005-04-21 2009-05-05 Microsoft Corporation Peer-to-peer multicasting using multiple transport protocols
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
EP2222299B1 (en) * 2007-11-19 2011-11-23 Bausch & Lomb Incorporated Use of levocabastine for modulating generation of pro-inflammatory cytokines

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE413459B (sv) * 1972-12-22 1980-06-02 Sandoz Ag Forfarande for framstellning av ett mot rinit verksamt, farmacentiskt kombinationspreparat innehallande 1-metyl-2-(alfa-metyl-p-klordifenylmetyloxi)-etyl)-pyrrolidin och 2-amino-1-fenylpropanol
US3936528A (en) * 1974-02-13 1976-02-03 Syntex Corporation Analgesic formulations having enhanced therapeutic activity
IT1064751B (it) * 1976-07-09 1985-02-25 Acraf P. isobutil idratropato di guaiacolo
US4115589A (en) * 1977-05-17 1978-09-19 The Upjohn Company Compounds, compositions and method of use
US4337255A (en) * 1977-07-29 1982-06-29 E. R. Squibb & Sons, Inc. Pyrazolo[1,5-c]quinazoline derivatives and related compounds
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
US4316884A (en) * 1979-01-25 1982-02-23 Adria Laboratories, Inc. Sustained release pharmaceutical formulation
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
CA1194799A (en) * 1981-12-10 1985-10-08 Eric L. Nelson Method and composition for reducing menstrual pain
IT1190663B (it) * 1982-01-21 1988-02-24 Ausonia Farma Srl Composto ad attivita' antiinfiammatoria,analgesica e mucoregolatrice,procedimento per la sua preparazione e relative composizioni farmaceutiche
IT1148117B (it) * 1982-03-05 1986-11-26 Medosan Ind Biochimi Attivita'antiflogistica,analgesica,antipiretica,mucolitica e seda tiva della tosse dell'1 metil-5-p-tolilpirrol-2-acetato di 2'metossi-fenile
US4656177A (en) * 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4587249A (en) * 1982-07-22 1986-05-06 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4777174A (en) * 1982-07-22 1988-10-11 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4464376A (en) * 1982-07-22 1984-08-07 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
AU570937B2 (en) * 1982-12-09 1988-03-31 Stephen A. Cooper Synergistic composition of hydroxyzine and salts thereof with nsaids
US4479956A (en) * 1983-04-26 1984-10-30 Analgeic Associates Analgesic compositions comprising propiram and methods of using same
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
ATE50493T1 (de) * 1986-11-14 1990-03-15 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US5183665A (en) * 1989-01-23 1993-02-02 Nitto Denko Corporation Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
GB8905815D0 (en) * 1989-03-14 1989-04-26 Beecham Group Plc Medicament
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
AU2100795A (en) * 1994-06-06 1996-01-04 Warner-Lambert Company Non-sedating allergy sinus medication
JPH11510168A (ja) * 1995-07-28 1999-09-07 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸障害を処理するための鎮痛剤及び抗ヒスタミン剤を含有する組成物及び方法

Also Published As

Publication number Publication date
US5648358A (en) 1997-07-15
JP2000506167A (ja) 2000-05-23
AU1989697A (en) 1997-09-22
NZ331575A (en) 2000-06-23
WO1997032586A1 (en) 1997-09-12
EP0886520A1 (en) 1998-12-30
CN1212625A (zh) 1999-03-31
CA2247500A1 (en) 1997-09-12

Similar Documents

Publication Publication Date Title
BR9707922A (pt) Cafeína e clemastina para tratamento de distúrbios respiratórios
EE9900607A (et) Imidasopürimidiinid ja imidasopüridiinid neuroloogiliste häirete käitlemiseks
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
PT861081E (pt) Utilizacao de epinastina para o tratamento de dores
BR9711530A (pt) Combina-Æo de terapia para tratamento de psicoses
SG100767A1 (en) Sulfonamides for treatment of endothelin-mediated disorders
NO20014674D0 (no) Fremgangsmåte for behandling av neurologiske og neuropsykiatriske forstyrrelser
PL328627A1 (en) Vaccine against the syndrome of reproductive and respiratory disorders among swine
DE69434492D1 (de) Phosphodiesterase des menschlichen gehirns
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
IL125557A0 (en) Use of lhrh-analogs and anti-estrogens for treating gynaecological disorders
EP1030663A4 (en) TREATMENT OF FIBROMYALGIA AND RELATED DISEASES
DE59707096D1 (de) Haarbehandlungsmittel zur Festigung der Haare
EP1126850A4 (en) TREATMENT OF CONDITIONS OF THE RETINA
HK1112738A1 (en) Arylsulfonamides and analogues as well as use for the treatment of neuro- degenerative disorders
BR9712030A (pt) Uso de benzopiranÄis para o tratamento de desordens neurolÄgicas
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
HK1022267A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis
ID17647A (id) Zat untuk propilaksis dan pengobatan untuk gangguan dari fungsi penglihatan
IL131347A0 (en) Treatment of skin disorders
BR9608595A (pt) Utilização de n-cicloexil benzamidas para o tratamento de aglições intestinais
NO952411D0 (no) Midler for behandling av metaboliske bensykdommer
PT1011678E (pt) Utilização de mecamilamina para o tratamento de perturbações neuropsiquiátricas responsivas à nicotina.
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES.